Clincosm LogoSign in Get a demo

Recurrent Prostate Carcinoma

Showing 1 - 25 of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Atlanta, Johns Creek (drug, other, procedure)

Not yet recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Atlanta, Georgia
  • +3 more
Mar 9, 2023

Localized Prostate Carcinoma, Locally Advanced Cervical Carcinoma, Locally Advanced Rectal Carcinoma Trial in Duarte (procedure,

Recruiting
  • Localized Prostate Carcinoma
  • +17 more
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Feb 1, 2023

Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester

Active, not recruiting
  • Metastatic Prostate Adenocarcinoma
  • +6 more
  • Intensity-Modulated Radiation Therapy
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)

Active, not recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Abiraterone Acetate
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial

Active, not recruiting
Has Results
  • Hormone-Resistant Prostate Cancer
  • +6 more
  • Pembrolizumab
  • pTVG-HP Plasmid DNA Vaccine
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 8, 2022

Castration-Resistant Prostate Carcinoma, Hormone-Resistant Prostate Cancer, PSA Progression Trial in Portland (drug, other,

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 26, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues

Active, not recruiting
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • San Francisco, California
  • +1 more
Sep 20, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Los Angeles (99mTc-based PSMA Imaging and Surgery Agent, Computed

Recruiting
  • Prostate Carcinoma
  • Recurrent Prostate Carcinoma
  • 99mTc-based PSMA Imaging and Surgery Agent
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 21, 2022

Metastatic Malignant Tumor in the Prostate Gland, Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Los Angeles

Recruiting
  • Metastatic Malignant Neoplasm in the Prostate Gland
  • +2 more
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 18, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Portland, Seattle

Active, not recruiting
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Portland, Oregon
  • +2 more
Jun 24, 2022

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Houston (Computed

Not yet recruiting
  • Metastatic Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Prostate Adenocarcinoma, PSA Progression, Recurrent Prostate Carcinoma Trial in Palo Alto (Gallium Ga 68 DOTA-NeoBOMB1, Gallium

Suspended
  • Prostate Adenocarcinoma
  • +2 more
  • Gallium Ga 68 DOTA-NeoBOMB1
  • Gallium Ga 68 PSMA-R2
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
May 3, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Abiraterone Acetate,

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Abiraterone Acetate
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 23, 2022

Serum Samples in Studying Emotional Stress in Prostate Cancer

Completed
  • Hormone-Resistant Prostate Cancer
  • +5 more
  • Biospecimen Collection
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Mar 8, 2022

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Enzalutamide,

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 23, 2022

Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy

Active, not recruiting
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • Quality-of-Life Assessment
  • Scottsdale, Arizona
  • +2 more
Feb 3, 2022

Recurrent Prostate Carcinoma Trial in Los Angeles, San Francisco (other, procedure, radiation)

Active, not recruiting
  • Recurrent Prostate Carcinoma
  • Best Practice
  • +3 more
  • Los Angeles, California
  • +1 more
Feb 2, 2022

Prostate Cancer, Recurrent Prostate Carcinoma, Stage IV Prostate Adenocarcinoma Trial in Baltimore (Ipilimumab, Nivolumab,

Completed
Has Results
  • Prostate Cancer
  • +2 more
  • Ipilimumab
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Jan 6, 2022

Prostate Adenocarcinoma, PSA Level Greater Than 0.2, PSA Level Greater Than or Equal to Two Trial in Palo Alto (procedure,

No longer available
  • Prostate Adenocarcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
Jan 6, 2022

Prostate Adenocarcinoma, PSA Failure, Recurrent Prostate Carcinoma Trial in Palo Alto (Computed Tomography (CT) scan,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +2 more
  • Computed Tomography (CT) scan
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
Jan 6, 2022

Blood and Tissue Samples From Locally Recurrent or Metastatic

Recruiting
  • Localized Renal Pelvis and Ureter Urothelial Carcinoma
  • +10 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 21, 2021

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Recurrent Prostate Carcinoma Trial in Buffalo,

Completed
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • Radiation Therapy
  • Buffalo, New York
  • +1 more
Aug 4, 2021

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Los Angeles, Ann Arbor,

Terminated
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Los Angeles, California
  • +2 more
Aug 3, 2021